PubRank

M R Mardiney

Author PubWeight™ 51.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bacterial proliferation in platelet products stored at room temperature. Transfusion-induced Enterobacter sepsis. N Engl J Med 1971 1.49
2 The ubiquitous occurrence of immune complex localization in the renal glomeruli of normal mice. Lab Invest 1973 1.42
3 Ultrastructural localization of the third and fourth components of complement on complement-cell complexes. Am J Pathol 1968 1.39
4 Nephrotoxic serum nephritis in complement intact and deficient mice. J Immunol 1967 1.33
5 Immune complex disease in the kidneys of lymphoma-leukemia patients: the presence of an oncornavirus-related antigen. J Natl Cancer Inst 1973 1.23
6 Immunology and morphology of acute post-streptococcal glomerulonephritis. Lab Invest 1966 1.22
7 Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease. Am J Med 1977 1.22
8 Subclinical immune complexes in the glomeruli of kidneys postmortem. Am J Med 1974 1.21
9 The in vitro transformation of frozen-stored lymphocytes in the mixed lymphocyte reaction and in culture with phytohemagglutinin and specific antigens. J Exp Med 1970 1.19
10 Postinfectious leukoencephalitis complicating Mycoplasma pneumoniae infection. Arch Neurol 1983 1.12
11 Reactivity of human lymphocytes to autologous and homologous serum. J Immunol 1969 1.04
12 The vascular pathology of thrombotic thrombocytopenic purpura. An immunohistochemical and ultrastructural study. Lab Invest 1966 1.03
13 The demonstration of cell-associated immunity to viruses. In vitro lymphocyte responsiveness to Varicella-zoster antigen. J Immunol Methods 1976 0.99
14 The relationship between rubella hemagglutination inhibition antibody (HIA) and rubella induced in vitro lymphocyte tritiated thymidine incorporation. Cell Immunol 1973 0.98
15 Dose response of IgE and IgG antibodies during ragweed immunotherapy. J Allergy Clin Immunol 1984 0.98
16 The characteristics of lymphocyte tritiated thymidine incorporation in response to mumps virus. Cell Immunol 1972 0.96
17 Production of tumor-specific antibody in the xenogeneic host: use of blocking antibody. J Natl Cancer Inst 1972 0.95
18 Isolation of leukemic blasts from peripheral blood by density gradient centrifugation. J Lab Clin Med 1970 0.95
19 Cell-associated immunity to measles (rubeola). The demonstration of in vitro lymphocyte tritiated thymidine incorporation in response to measels complement fixation antigen. Cell Immunol 1975 0.94
20 Preservation of cellular antigenicity of tumor cells by the use of formalin fixation. Cancer Res 1972 0.92
21 Immune complexes localized in the renal glomeruli of AKR mice: the presence of MuLV gs-I and C-type RNA tumor virus gs-3 determinants. Rev Eur Etud Clin Biol 1973 0.92
22 The effect of synthetic polynucleotides on immunologically induced tritiated thymidine incorporation. Amplification of response. Transplantation 1972 0.90
23 Subclinical immune complex nephritis in patients with Hodgkin's disease. Cancer Res 1974 0.89
24 Abnormal profile of human nucleolytic activity as a test for cancer. J Natl Cancer Inst 1975 0.88
25 Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcoma. Cancer Res 1976 0.87
26 Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola). Cell Immunol 1975 0.86
27 Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro. Cancer Treat Rep 1976 0.84
28 A comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol 1980 0.84
29 In vivo abrogation of serum C3 and C5 by administration of cobra venom factor and heterologous anti-C3. J Immunol Methods 1974 0.83
30 A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol 1980 0.83
31 Experience with a mixed lymphocyte-tumor reaction as a method of detecting antigenic differences between normal and neoplastic cells. J Immunol 1970 0.83
32 A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever. J Allergy Clin Immunol 1982 0.82
33 Purification of human lymphocytes by simple centrifugation. Rev Eur Etud Clin Biol 1970 0.82
34 The immunosuppressive effect of amantadine upon the response of lymphocytes to specific antigens in vitro. Transplantation 1971 0.82
35 Detection and quantitation of bacteria in platelet products stored at ambient temperature. Transfusion 1974 0.82
36 Alteration of human serum ribonuclease activity in malignancy. CRC Crit Rev Clin Lab Sci 1978 0.82
37 Transformation of mouse lymphocytes to allogeneic lymphocytes and phytohemagglutinin. J Immunol 1970 0.81
38 Repetitive administration of BCG in prevention and treatment of spontaneous leukemia of AKR mice. J Natl Cancer Inst 1973 0.81
39 Restoration of the reactivity of frozen stored human lymphocytes in the mixed lymphocyte reaction and in response to specific antigens. Transplantation 1972 0.81
40 The role of the human granulocyte as an antigen in the mixed lymphocyte reaction: the lack of stimulation. Transplantation 1972 0.81
41 Formalin-fixed cell preparations as standards for use in the automated trypan blue cytotoxic assay. Transplantation 1972 0.80
42 Parameters for effective use of synthetic double stranded polynucleotides in the amplification of immunologically induced lymphocyte tritiated thymidine incorporation. Cell Immunol 1974 0.80
43 Complexing Rauscher leukemia virus reverse transcriptase with human plasma ribonuclease from Hodgkin's disease patients. J Biol Chem 1977 0.80
44 Antibody response in patients with acute nonlymphocytic leukemia. Cancer 1976 0.79
45 Passive administration of antiserum and complement in producing anti-EL4 cytotoxic activity in the serum of C57BL-6 mice. J Natl Cancer Inst 1973 0.79
46 Mycoplasma contamination of membrane associated measles antigens. Inability to demonstrate in vitro lymphocyte responsiveness to measles. Cell Immunol 1975 0.79
47 Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response. J Natl Cancer Inst 1973 0.78
48 Sensitivity of mixed lymphocyte reaction and its correlation with skin graft survival. Transplant Proc 1971 0.78
49 Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing mice. Cancer Res 1975 0.76
50 Suppression of in vitro lymphocyte responsiveness to purified protein derivative by measles virus. A reexploration of the phenomenon. Cell Immunol 1975 0.76
51 The measurement and manipulation of hemolytic complement levels in tumor bearing C57BL/6 mice. Biomedicine 1973 0.76
52 The mixed lymphocyte reaction. Detection of single histocompatibility loci and the correlation to skin graft survival in mice. Transplantation 1971 0.76
53 Enhancement of spontaneous C3H/HeJ mammary tumorigenesis by long-term polyadenylic-polyuridylic acid therapy. Cancer Res 1975 0.75
54 Elevated ribonuclease activity in the thymus and white blood cells of genetically cancer prone mice. J Exp Med 1975 0.75
55 Binding studies concerning the interaction of radiolabeled sodium chromate with EL4 leukemia. Transplantation 1972 0.75
56 In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death. Biomedicine 1976 0.75
57 Comparative effects of different polynucleotide complexes on the immune response of human peripheral blood lymphocytes. Transplantation 1976 0.75
58 The effect of synthetic polyribonucleotides on EL-4 lymphoma. J Reticuloendothel Soc 1975 0.75
59 An improved system for controlled rate cooling of biological material. Cryobiology 1972 0.75
60 Latent homology of murine lymphoid antigens revealed through the complement mediated absorption of xenogeneic antiserum. Biomedicine 1976 0.75
61 The age-dependent efficacy of polyadenylic-polyuridylic acid therapy upon the development of spontaneous leukemia in AKR mice. Cancer Res 1976 0.75
62 Complement-mediated alteration of antibody specificity in vivo. J Immunol 1975 0.75
63 The correlation of PHA induced polyamine changes in human lymphocytes with tritiated thymidine incorporation. Biomedicine 1974 0.75
64 Parameters of serum complement in relation to tumor therapy. Biomedicine 1974 0.75
65 Light transmission analysis of lymphocyte activation by mitogens: a new technique. J Immunol Methods 1978 0.75
66 The kinetics of the interaction of heterologous anti-tumor serum and heterologous complement in non-tumor bearing mice. Biomedicine 1975 0.75
67 The effects of adrenergic agonists and blockers on antigen-induced DNA synthesis in vitro. Biomedicine 1977 0.75
68 Carcinoma of the lung and cigarette smoking. Effect on serum ribonuclease activity. JAMA 1978 0.75
69 Alteration of the specificity of antitumor antisera by the use of passively administered antibody. Cancer Res 1972 0.75
70 Positive long-acting thyroid stimulator response in the complement-deficient mouse. Endocrinology 1967 0.75
71 Immunotherapy for leukemia: quantitative aspects and adjuvant relationships to chemotherapy. Cancer Chemother Rep 1969 0.75
72 A proper sequence for the treatment of B16 melanoma: chemotherapy, surgery, and immunotherapy. J Natl Cancer Inst 1976 0.75
73 Prophylactic therapy of spontaneous leukemia in AKR mice by polyadenylic-polyuridylic acid. J Natl Cancer Inst 1974 0.75
74 Depression of complement activity in tree strains of mice after tumor transfer. Int J Cancer 1973 0.75
75 Transformation response of frozen-stored chronic lymphocytic leukemia cells: a preliminary report. Rev Eur Etud Clin Biol 1971 0.75
76 Quantitative and qualitative analysis of human lymphocyte proliferation to specific antigen in vitro by use of the helium neon laser. J Immunol Methods 1977 0.75
77 The dependence of successful immunotherapy on adequate tumor burden as shown by the treatment of AKR leukemia with poly A-poly U. J Natl Cancer Inst 1975 0.75
78 A new apparatus for BCG scarification. J Natl Cancer Inst 1975 0.75
79 Epstein-Barr virus-immune complexes in postmortem kidneys from African patients with Burkitt's lymphoma and American patients with and without lymphoma. J Natl Cancer Inst 1978 0.75
80 Immunoprophylaxis and treatment of leukemia in AKR mice: repetitive use of BCG. Natl Cancer Inst Monogr 1973 0.75
81 In vitro discordance between actual lymphocyte proliferation and thymidine incorporation on exposure of human lymphocytes to specific antigen or allogeneic cells. Transplant Proc 1977 0.75
82 The prevention of clumping of frozen-stored leukocyte populations by EDTA. Cryobiology 1972 0.75
83 A current methodology for performing murine mixed lymphocyte reactions. Biomedicine 1973 0.75
84 Differences in potentiation of melanoma growth by absorbable and nonabsorbable suture. J Surg Oncol 1976 0.75
85 Characteristics of human IgE antibody responses in vivo. Monogr Allergy 1983 0.75
86 The enhancement of antitumor antibody binding to cross reactive normal tissue antigens. A complement-mediated effect. Transplantation 1973 0.75
87 The synergistic effect of synthetic polynucleotides and mercaptoethanol in amplifying the murine mixed lymphocyte reaction. Transplantation 1976 0.75
88 A white blood cell RNase assay for the possible monitoring of malignancy. J Natl Cancer Inst 1975 0.75
89 Augmentation of antitumor antisera activity by lyophilization. J Natl Cancer Inst 1973 0.75
90 Application of laser cytometry to the analysis of immunologically induced in vitro lymphocyte responsiveness. Transplantation 1977 0.75
91 The formalinization of antibody to tumor cells in altering the immune response. Cancer Res 1972 0.75
92 Alteration of cellular ribonucleases associated with murine oncogenic virus infection. Biomedicine 1978 0.75